vs
CULLEN/FROST BANKERS, INC.（CFR）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是CULLEN/FROST BANKERS, INC.的1.1倍（$622.0M vs $580.9M），Royalty Pharma plc净利率更高（34.4% vs 28.6%，领先5.8%），CULLEN/FROST BANKERS, INC.同比增速更快（8.3% vs 4.8%），过去两年CULLEN/FROST BANKERS, INC.的营收复合增速更高（7.6% vs 4.6%）
Frost Bank是总部位于美国圣安东尼奥的德克萨斯州特许银行，为银行控股公司卡伦/弗罗斯特银行家集团的核心子公司。其在得克萨斯州共设有200家营业网点、1750台自动柜员机，按总资产规模统计位列全美前60大银行之列。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
CFR vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.1倍
$580.9M
营收增速更快
CFR
高出3.5%
4.8%
净利率更高
RPRX
高出5.8%
28.6%
两年增速更快
CFR
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $580.9M | $622.0M |
| 净利润 | $166.3M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 34.1% | 62.4% |
| 净利率 | 28.6% | 34.4% |
| 营收同比 | 8.3% | 4.8% |
| 净利润同比 | 7.4% | 2.9% |
| 每股收益（稀释后） | $2.56 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CFRRPRX
| Q4 25 | $580.9M | $622.0M | ||
| Q3 25 | $567.3M | $609.3M | ||
| Q2 25 | $546.9M | $578.7M | ||
| Q1 25 | $540.2M | $568.2M | ||
| Q4 24 | $536.3M | $593.6M | ||
| Q3 24 | $518.0M | $564.7M | ||
| Q2 24 | $507.9M | $537.3M | ||
| Q1 24 | $501.4M | $568.0M |
净利润CFRRPRX
| Q4 25 | $166.3M | $214.2M | ||
| Q3 25 | $174.4M | $288.2M | ||
| Q2 25 | $157.0M | $30.2M | ||
| Q1 25 | $150.9M | $238.3M | ||
| Q4 24 | $154.9M | $208.2M | ||
| Q3 24 | $146.5M | $544.0M | ||
| Q2 24 | $145.5M | $102.0M | ||
| Q1 24 | $135.7M | $4.8M |
营业利润率CFRRPRX
| Q4 25 | 34.1% | 62.4% | ||
| Q3 25 | 36.7% | 70.1% | ||
| Q2 25 | 34.1% | 36.3% | ||
| Q1 25 | 33.2% | 94.0% | ||
| Q4 24 | 34.3% | 60.9% | ||
| Q3 24 | 33.8% | — | ||
| Q2 24 | 34.5% | 50.2% | ||
| Q1 24 | 32.2% | -13.0% |
净利率CFRRPRX
| Q4 25 | 28.6% | 34.4% | ||
| Q3 25 | 30.7% | 47.3% | ||
| Q2 25 | 28.7% | 5.2% | ||
| Q1 25 | 27.9% | 41.9% | ||
| Q4 24 | 28.9% | 35.1% | ||
| Q3 24 | 28.3% | 96.3% | ||
| Q2 24 | 28.6% | 19.0% | ||
| Q1 24 | 27.1% | 0.8% |
每股收益（稀释后）CFRRPRX
| Q4 25 | $2.56 | $0.49 | ||
| Q3 25 | $2.67 | $0.67 | ||
| Q2 25 | $2.39 | $0.07 | ||
| Q1 25 | $2.30 | $0.55 | ||
| Q4 24 | $2.36 | $0.46 | ||
| Q3 24 | $2.24 | $1.21 | ||
| Q2 24 | $2.21 | $0.23 | ||
| Q1 24 | $2.06 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $4.6B | $9.7B |
| 总资产 | $53.0B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资CFRRPRX
| Q4 25 | — | $618.7M | ||
| Q3 25 | — | $938.9M | ||
| Q2 25 | — | $631.9M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $929.0M | ||
| Q3 24 | — | $950.1M | ||
| Q2 24 | — | $1.8B | ||
| Q1 24 | — | $843.0M |
总债务CFRRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益CFRRPRX
| Q4 25 | $4.6B | $9.7B | ||
| Q3 25 | $4.5B | $9.6B | ||
| Q2 25 | $4.2B | $9.5B | ||
| Q1 25 | $4.1B | $9.8B | ||
| Q4 24 | $3.9B | $10.3B | ||
| Q3 24 | $4.1B | $10.3B | ||
| Q2 24 | $3.7B | $9.8B | ||
| Q1 24 | $3.6B | $9.9B |
总资产CFRRPRX
| Q4 25 | $53.0B | $19.6B | ||
| Q3 25 | $52.5B | $19.3B | ||
| Q2 25 | $51.4B | $18.3B | ||
| Q1 25 | $52.0B | $17.6B | ||
| Q4 24 | $52.5B | $18.2B | ||
| Q3 24 | $51.0B | $18.0B | ||
| Q2 24 | $48.8B | $17.7B | ||
| Q1 24 | $49.5B | $16.1B |
负债/权益比CFRRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $274.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $127.3M | — |
| 自由现金流率自由现金流/营收 | 21.9% | — |
| 资本支出强度资本支出/营收 | 25.2% | — |
| 现金转化率经营现金流/净利润 | 1.65× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $116.4M | — |
8季度趋势，按日历期对齐
经营现金流CFRRPRX
| Q4 25 | $274.0M | $827.1M | ||
| Q3 25 | $248.6M | $702.6M | ||
| Q2 25 | $140.8M | $364.0M | ||
| Q1 25 | $-296.1M | $596.1M | ||
| Q4 24 | $989.5M | $742.5M | ||
| Q3 24 | $307.2M | $703.6M | ||
| Q2 24 | $129.6M | $658.2M | ||
| Q1 24 | $488.4M | $664.6M |
自由现金流CFRRPRX
| Q4 25 | $127.3M | — | ||
| Q3 25 | $211.7M | — | ||
| Q2 25 | $114.5M | — | ||
| Q1 25 | $-337.1M | — | ||
| Q4 24 | $861.8M | — | ||
| Q3 24 | $281.9M | — | ||
| Q2 24 | $103.0M | — | ||
| Q1 24 | $450.3M | — |
自由现金流率CFRRPRX
| Q4 25 | 21.9% | — | ||
| Q3 25 | 37.3% | — | ||
| Q2 25 | 20.9% | — | ||
| Q1 25 | -62.4% | — | ||
| Q4 24 | 160.7% | — | ||
| Q3 24 | 54.4% | — | ||
| Q2 24 | 20.3% | — | ||
| Q1 24 | 89.8% | — |
资本支出强度CFRRPRX
| Q4 25 | 25.2% | — | ||
| Q3 25 | 6.5% | — | ||
| Q2 25 | 4.8% | — | ||
| Q1 25 | 7.6% | — | ||
| Q4 24 | 23.8% | — | ||
| Q3 24 | 4.9% | — | ||
| Q2 24 | 5.2% | — | ||
| Q1 24 | 7.6% | — |
现金转化率CFRRPRX
| Q4 25 | 1.65× | 3.86× | ||
| Q3 25 | 1.43× | 2.44× | ||
| Q2 25 | 0.90× | 12.06× | ||
| Q1 25 | -1.96× | 2.50× | ||
| Q4 24 | 6.39× | 3.57× | ||
| Q3 24 | 2.10× | 1.29× | ||
| Q2 24 | 0.89× | 6.45× | ||
| Q1 24 | 3.60× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CFR
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
